ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1272

Application of the Consolidated Framework for Implementation Research (CFIR) to Study Top-Performing Practices in the RISE Registry

Lindsay Jacobsohn1, Catherine Nasrallah2, Cammie Young3, Gabriela Schmajuk4 and Jinoos Yazdany5, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, 3University of California San Francisco, San Francisco, CA, 4UCSF / SFVA, San Francisco, CA, 5UCSF, San Francisco, CA

Meeting: ACR Convergence 2022

Keywords: Health Services Research, Patient reported outcomes, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Measures and Measurement of Healthcare Quality Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Collection and use of rheumatoid arthritis (RA) disease activity and functional status outcome measures facilitates treating-to-target and shared decision-making. Although guidelines recommend regular use of these measures and most rheumatologists agree on their value, implementation in a busy clinical practice can be challenging. Indeed, collection of these measures varies widely in RISE registry practices. In this study, we used the Consolidated Framework for Implementation Research (CFIR) as an evaluation framework to study practices that reliably collect RA measures.

Methods: We used purposive sampling among RISE practices with a high proportion of patients with documented RA outcome measures (top quartile across all RISE practices). Because academic medical centers (AMCs) are under-represented in RISE, we also sampled several high-performing AMCs. A rheumatologist and key staff from each practice involved in RA measure collection were invited for a group interview. A semi-structured interview guide was developed using concepts from the CFIR framework. Recorded interviews were transcribed, and deductive and inductive thematic analysis was used to identify key themes. We organized themes and sub-themes into components within CFIR domains.

Results: We conducted 29 interviews across 10 RISE practices and 5 AMCs (16 rheumatologists, 6 medical assistants, 5 practice managers, 1 nurse practitioner, and 1 IT specialist). Common themes in successful implementation of RA measure collection were discussed by participants in the following CFIR domains (Table 1): 1) Process: practices had clearly defined workflows for collecting RA outcomes and well-defined roles for staff and physicians in collecting RA measure information (Figure 1); 2)

Intervention: practices tailored RA measure collection procedures to their clinical context, employing everything from simple paper forms to digital applications supplied by an outside vendor or within the EHR; 3) Characteristics of individuals: nearly all participants emphasized that clinic culture was important to their success. The idea of “checks and balances,” or ensuring multiple staff members are responsible for collection of RA measures, was common; 4) Inner setting: capacity for rapid adjustments to workflows was common, with many practices reporting the ability to implement changes quickly as needed; 5) Outer setting: although external quality reporting programs necessitated measure collection, most respondents relayed that this was rarely the primary driver of their performance. Instead, rheumatologists felt motivated to provide high quality, evidence-based care to patients. Despite their success in collecting RA measures, respondents also identified a number of challenges (Table 2).

Conclusion: Rheumatology practices that successfully collect RA measures reported having well-defined workflows, a culture of accountability, and being motivated by patients and evidence as opposed to external factors such as pay-for performance programs. Next steps include using these qualitative findings to build a quality improvement toolkit to disseminate to rheumatology practices nationwide.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: L. Jacobsohn, None; C. Nasrallah, None; C. Young, None; G. Schmajuk, None; J. Yazdany, AstraZeneca, Gilead, Bristol-Myers Squibb(BMS), Aurinia, Astra Zeneca, Pfizer.

To cite this abstract in AMA style:

Jacobsohn L, Nasrallah C, Young C, Schmajuk G, Yazdany J. Application of the Consolidated Framework for Implementation Research (CFIR) to Study Top-Performing Practices in the RISE Registry [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/application-of-the-consolidated-framework-for-implementation-research-cfir-to-study-top-performing-practices-in-the-rise-registry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/application-of-the-consolidated-framework-for-implementation-research-cfir-to-study-top-performing-practices-in-the-rise-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology